Moayeri, M. The SlideShare family just got bigger. Home Explore Login Signup. Successfully reported this slideshow. We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Next SlideShares. You are reading a preview. Create your free account to continue reading. Sign Up. Upcoming SlideShare. Polycystic ovary syndrome. Embed Size px. Start on. Show related SlideShares at end. WordPress Shortcode. Share Email. Top clipped slide. Download Now Download Download to read offline. OC Fertility Follow. PCOS management. Prepubertal development of GABAergic transmission to gonadotropin-releasing hormone GnRH neurons and postsynaptic response are altered by prenatal androgenization.
Valproate: past, present, and future. CNS Drug Rev. Increased cerebrospinal fluid levels of GABA, testosterone and estradiol in women with polycystic ovary syndrome. Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS.
JCI Insight. Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome type A insulin resistance. N Engl J Med. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic—hyperinsulaemic clamp.
Insulin resistance, hyperinsulinemia, and mitochondria dysfunction in nonobese girls with polycystic ovarian syndrome. Selective insulin action on skin, ovary, and heart in insulin-resistant states. Diabetes Care.
Reproductive tissues maintain insulin sensitivity in diet-induced obesity. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Caprio S. Insulin: the other anabolic hormone of puberty. Acta Paediatr Suppl. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.
Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.
Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Abnormal infant islet morphology precedes insulin resistance in PCOS-like monkeys.
Sci Rep. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome—an allostatic perspective.
Biochim Biophys Acta. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. Grundy SM. Overnutrition, ectopic lipid and the metabolic syndrome. J Investig Med. Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. Adipose insulin resistance in normal-weight women with polycystic ovary syndrome. Normalizing ovulation rate by preferential reduction of hepato-visceral fat in adolescent girls with polycystic ovary syndrome.
J Adolesc Health. Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome. Osmond C, Barker DJ.
Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ Health Perspect. Age at adiposity rebound in childhood is associated with PCOS diagnosis and obesity in adulthood-longitudinal analysis of BMI data from birth to age 46 in cases of PCOS [published online ahead of print 4 February ]. Int J Obes Lond. Hyperinsulinaemic androgen excess in adolescent girls [published correction appears in Nat Rev Endocrinol. Obesity Silver Spring.
AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome. Understanding androgen action in adipose tissue. J Steroid Biochem Mol Biol. Impaired lipolysis, diminished fat oxidation, and metabolic inflexibility in obese girls with polycystic ovary syndrome.
Combined androgen excess and Western-style diet accelerates adipose tissue dysfunction in young adult, female nonhuman primates. Filippou P, Homburg R. Is foetal hyperexposure to androgens a cause of PCOS? Developmental origin of polycystic ovary syndrome—a hypothesis. J Endocrinol. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Witchel SF. Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol. Abbott DH, Bacha F.
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood. Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure.
J Dev Orig Health Dis. Impaired preadipocyte differentiation into adipocytes in subcutaneous abdominal adipose of PCOS-like female rhesus monkeys. Sex differences in androgen regulation of metabolism in nonhuman primates.
Adv Exp Med Biol. Emerging role of the gut microbiome in nonalcoholic fatty liver disease: from composition to function. Clin Gastroenterol Hepatol. Human gut microbes impact host serum metabolome and insulin sensitivity.
Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity. Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism.
Thackray VG. Sex, microbes, and polycystic ovary syndrome. Heritability of polycystic ovary syndrome in a Dutch twin-family study. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p Nat Genet. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations [published correction appears in Nat Commun.
Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Evolutionary determinants of polycystic ovary syndrome: part 2. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. Family-based quantitative trait meta-analysis implicates rare noncoding variants in DENND1A in polycystic ovary syndrome [published online ahead of print 30 April ].
Epigenetic and transcriptional alterations in human adipose tissue of polycystic ovary syndrome [published correction appears in Sci Rep. Transcriptional and epigenetic changes influencing skeletal muscle metabolism in women with polycystic ovary syndrome. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome.
Accessed 17 February Criteria, prevalence, and phenotypes of polycystic ovary syndrome. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr. The diagnosis of polycystic ovary syndrome during adolescence. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and hydroxylase-deficient nonclassic adrenal hyperplasia.
Age of menarche in a longitudinal US cohort. Age at menarche and racial comparisons in US girls. Rapid maturation of the reproductive axis during perimenarche independent of body composition. Vihko R, Apter D. Endocrine characteristics of adolescent menstrual cycles: impact of early menarche.
J Steroid Biochem. The majority of irregular menstrual cycles in adolescence are ovulatory: results of a prospective study. Arch Dis Child. Menstrual patterns in the first gynecological year: a systematic review. Healthy post-menarchal adolescent girls demonstrate multi-level reproductive axis immaturity. Variation of the human menstrual cycle through reproductive life. Int J Fertil.
Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. The prognosis for adolescents with menstrual abnormalities. Am J Obstet Gynecol.
Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. Visually scoring hirsutism. Toward excellence in testosterone testing: a consensus statement. A sensitive and rapid mass spectrometric method for the simultaneous measurement of eight steroid hormones and CALIPER pediatric reference intervals. Clin Biochem. Clinical significance of oxygenated androgens. A new dawn for androgens: novel lessons from oxygenated C19 steroids.
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
Polycystic ovarian morphology in postmenarchal adolescents. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche.
Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. Is anti-Mullerian hormone a good diagnostic marker for adolescent and young adult patients with Polycystic ovary syndrome?
Turk J Obstet Gynecol. Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents. J Pediatr Endocrinol Metab. Sultan C, Paris F. Clinical expression of polycystic ovary syndrome in adolescent girls. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. Cree-Green M.
Worldwide dissatisfaction with the diagnostic process and initial treatment of PCOS. Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Interventions for treating children and adolescents with overweight and obesity: an overview of Cochrane reviews. Int J Obes.
Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. Health-related quality of life in adolescents and young adults with polycystic ovary syndrome: a systematic review.
Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis. The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials.
Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin.
Effect of weight loss on menstrual function in adolescents with polycystic ovary syndrome. Effect of dietary weight loss on menstrual regularity in obese young adult women with polycystic ovary syndrome.
A randomized pilot study of dietary treatments for polycystic ovary syndrome in adolescents. Pediatr Obes. Systematic review of the relationships between objectively measured physical activity and health indicators in school-aged children and youth. Appl Physiol Nutr Metab.
Exercise therapy in polycystic ovary syndrome: a systematic review. Role of exercise training in polycystic ovary syndrome: a systematic review and meta-analysis.
Clin Obes. Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: a randomized control trial. Int J Yoga. Systematic review of sedentary behaviour and health indicators in school-aged children and youth: an update. Cognitive—behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study.
J Pediatr Psychol. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis. J Obstet Gynaecol. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr.
Metformin prescription patterns among US adolescents aged 10—19 years: — J Clin Pharm Ther. Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study. Jun 30; 95 8 — Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome.
Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome. Arch Pediatr Adolesc Med. Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome. Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 month follow up period.
Middle East Fertil Soc J. Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis. Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. Treatment options for hirsutism: a systematic review and network meta-analysis. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome.
Int J Gynaecol Obstet. A randomized crossover study of medroxyprogesterone acetate and Diane in adolescent girls with polycystic ovarian syndrome. Pasquali R, Gambineri A. Therapy in endocrine disease: treatment of hirsutism in the polycystic ovary syndrome. Eur J Endocrinol. Somani N, Turvy D. Hirsutism: an evidence-based treatment update. Am J Clin Dermatol. Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
Br J Dermatol. Electrolysis and thermolysis for permanent hair removal. J Am Acad Dermatol. The effect of eflornithine Int J Dermatol. Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl Laser hair removal: a review.
Dermatol Surg. Laser and photoepilation for unwanted hair growth. Unwanted facial hair removal with laser treatment improves quality of life of patients. J Cosmet Laser Ther. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome.
Guidelines on the safety of light-based home-use hair removal devices from the European Society for Laser Dermatology. J Eur Acad Dermatol Venereol. Light-based home-use devices for hair removal: why do they work and how effective they are?
Lasers Surg Med. A systematic review of light-based home-use devices for hair removal and considerations on human safety. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.
Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism. Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Mwanthi M, Zaenglein AL. Update in the management of acne in adolescence.
Curr Opin Pediatr. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression.
Quality of life in adolescent girls with polycystic ovary syndrome. Health-related quality of life among adolescents with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs. Psychological aspects of hyperandrogenic states in late adolescent and young women. Pediatric obesity—assessment, treatment, and prevention: an Endocrine Society clinical practice guideline.
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. Goldenring J, Cohen E. Contemp Pediatr. Androgenic Symptoms Cosmetic treatment of hirsutism, acne, and alopecia is an option for women dealing with the hyperandrogenic manifestations of PCOS.
Oral contraceptives. Other Therapies Medroxyprogesterone acetate. Footnotes Disclosure: The authors report no financial or commercial relationships with regard to this article. Menstruation-related disorders. Pharmacotherapy: A Pathophysiologic Approach. New York: McGraw-Hill; Androgen receptor gene polymorphism and polycystic ovary syndrome. Int J Gynaecol Obstet. Aubuchon M, Legro RS. Polycystic ovary syndrome: Current infertility management.
Clin Obstet Gynecol. American Congress of Obstetricians and Gynecologists. Obstet Gynecol. Available at: www. Accessed March 27, McFarland C. Treating polycystic ovary syndrome and infertility. The genetic basis of polycystic ovary syndrome. Eur J Endocrinol. The role of genes and environment in the etiology of PCOS.
Shannon M, Wang Y. Polycystic ovary syndrome: A common but often unrecognized condition. J Midwifery Womens Health. Urbanek M. The genetics of polycystic ovary syndrome. Natl Clin Pract Endocrinol Metab. Polycystic ovary syndrome: Pathogenesis and treatment over the short and long term. Cleve Clin J Med. Strauss JF. Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome.
Ann NY Acad Sci. Position statement: Criteria for defining polycystic ovary syndrome as a predominantly hyper-androgenic syndrome. An Androgen Excess Society guideline.
J Clin Edocrinol Metab. Polycystic ovarian syndrome: Role of imaging in diagnosis. Legro RS. Polycystic ovarian syndrome: Current and future treatment paradigms. Am J Obstet Gynecol. Guzick DS. Polycystic ovary syndrome. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev.
Clomid clomiphene , prescribing information. Bridgewater, N. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Insulin-sensitising drugs metformin, rosiglitazone, pioglitazone, d-chiro-inositol for women with polycystic ovary syndrome, oligoamenorrhoea, and subfertility.
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome. J Clin Endrocrinol Metab. A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome.
0コメント